KDM3A and nonpapillary renal cell carcinoma: Thus, to further address the mechanisms by which KDM3A promotes the oncogenic phenotype in ccRCC, we first investigated gene alteration in the Hippo pathway after KDM3A knockdown in 786-O cells.